Showing posts with label CELG. Show all posts
Showing posts with label CELG. Show all posts

Tuesday, October 14, 2014

Now That The Correction Is In Full Swing What To Expect Next

After warning for weeks, and several attempts over the last year, the market is finally in its first real correction since 2012. Any attempt to rally or reverse intra-day losses, has been quickly met with more selling the very next day or closes near the lows of the day. 

Volume has clearly favored the downside and the NYSE and NASDAQ advance declines lines are leading their respective markets to new lows. But, the market is now getting over extended, and based on historical studies, closer to a multi-week rally attempt to test the their respective fifty day moving averages before resuming the downtrend. Ideally, the NASDAQ will test the 3,900 - 4,000 range to shakeout enough investors and setup the last major leg of the bull market.

The majority of leading growth stocks have suffered significant damage over the last couple of weeks, but not to the extent they couldn't repair themselves over the next few weeks or months. Biotech's, Celgene (CELG), Gilead Sciences (GILD), and Biogen Idec (BIIB), and semiconductor stocks, Avago (AVGO) and Skyworks Solutions (SWKS), which appeared to be weathering the correction so well, succumbed to heavy selling over the last few days.

As the correction progresses, not all leading growth stocks will follow the market lower. Some will tighten, finish up consolidations, and be ready to breakout before the market bottoms. Apple (AAPL) has been forming a flat base ahead of its Ipad Event Thursday, October 16th, and earning's report Monday, October 20th. Medivation (MDVN) has been pulling pack to the fifty day moving average in low volume, digesting a 30% gain since breaking out of a first stage cup and handle base on August 7th, in volume 350% above average. The stock was a featured trading idea on July 28th, Biotech Company Ready To Explode on Earnings. EPAM Systems (EPAM) has formed a second stage cup and handle base.

Short trading ideas have performed exceptionally well, breaking down and following through, but are now over extended from proper entry points. While the original group of stocks have followed through, recent setups have not been as profitable, trading wildly. While new setups appear tempting, most are now considered to be lagging the market and much more prone to failure. Gulfport Energy (GPOR), Pentair  (PNR), Covance (CVD), and UBS AG (UBS) continue lower.

With the market and most short trading ideas over extended, short traders cannot get too complacent. Traders need to start reducing recent positions that have failed to follow through and tightening stops on positions with significant profits. While it may be tempting to ride through the first market test of the fifty day moving average, it could be extremely painful, especially if the market doesn't stop and attempts to test new highs. If the market correction is going to deepen after the test of the fifty day moving average, most current positions will offer better short entry opportunities.

Wednesday, October 08, 2014

Largest Price Swings Occur During Corrections

The market gapped down Wednesday but found support at last week's correction lows and started to rally around 11:15 am. Volume was running heavy to the downside in the morning and accelerated as the market exploded higher after the FED minutes were released at 2:00 pm. By the close, all three major indices were up over 1.5% in the second heaviest trade since the end of June. If all three indices had not taken out last week's correction  lows earlier in the day, today would've have been considered a fifth day follow through.

The FED knows that any hint of an accelerated time table for raising rates would spook the markets and would lead to an irrational downside reaction. So they will try, for as long as possible, to keep the bears at bay, even though their time tables have not changed.

China has continued its strong uptrend, but the rest of the world, especially Europe, have continued their corrections, and need time to digest recent losses before firming up for a rally, which could take weeks with further downside.

The VIX marked new correction highs but reversed significantly as the market rallied. The NYSE and NASDAQ advance decline lines and the fifty two week high low ratio marked new lows for the correction and barely bounced with the strong afternoon rally.

Keep an eye on interest rates, they are near recent support levels. If these levels hold, there could be a significant spike in interest rates over the next few weeks despite the FED's apparent dovish stance, which could put further pressure on the stock market. 

Leading growth stocks still need time to setup. There are very few stocks that are ready to breakout, and most are from late stage consolidations, but in strong industry groups. Biotech stocks Gilead Sciences (GILD) and Celgene (CELG) are ready to breakout of flat bases, and Medivation (MDVN) and United Therapeutics (UTHR) are bouncing off their respective twenty day moving averages.

Short trading ideas squeezed along with the market, but most did not experience any unusual trading activities associated with a bottom. Recent breakdowns 3D Systems (DDD), UBS AG (UBS), and Avon Products (AVP) held up well and digested their recent gains.

The market was over-extended at the lows of the day and bulls took solace in its ability to hold support, a continued dovish stance by the FED, and a lack of bad news. As impressive as the day appeared, traders have to keep in mind that the biggest percent moves tend to occur during corrections and are nothing to get excited about initially.

There's little reason to cover most short positions or rush into long positions, but traders need to keep an eye on the action over the next few days to decide how tight to tighten stops to protect profits. The market may follow through today's gains as earning's season gets underway, but it will be important to see if volume continues to confirm the move or the market begins to stall around moving averages. Stay patient and do not panic.

Thursday, June 26, 2014

Market Distribution Joins Growing List of Sell Signals

The market has rallied despite uncertainty surrounding Ukraine, Iraq, the economy, and upcoming earnings. Price action has been impressive, shaking out early in the day and closing higher or at the high's of the day on most days, but below average volume has been a major concern. Over the last two weeks, volume has expanded, still below average, but the market has failed to make much progress. Most of the higher volume days have either stalled or turned into a distribution day, higher volume selling. The lead index, the SP 500, has experienced four to five distribution days over the last three weeks, a major warning signal.

The NYSE advance/decline line continues to make new highs, but the fifty two week high low ratio has fallen despite the market trading at fifty two week highs...less stocks are participating in the upside. The VIX and bull bear ratios indicate extreme investor complacency, trading near bull market extremes. Interest rates have been falling and gold has been rising. A stealth attempt to rush to safety? 

Leading growth stocks have lagged the entire rally. They have shown signs of life on several occasions, but have failed to sustain any momentum. Value stocks have been the clear leaders and the market has behaved accordingly, choppy and difficult to make progress in. Early breakouts have either become over extended, exhibiting climactic action, or lack volume, with many failing to make much progress. Relative strength has failed to confirm many recent breakouts, and most are late stage, wild and loose consolidations.

Netflix's (NFLX) handle has been wedging along the lows. Pacira Pharmaceuticals (PCRX) is a wild and loose, late stage breakout in weak volume. Celgene (CELG) broke out of a v-shaped cup and handle but the relative strength line has not confirmed. Hi-Crush Partners (HCLP) is extended historically and in the midst of a potential climax run, up over 25% in a few weeks after a long advance. Bidu (BIDU) and FaceBook (FB) have attempted to breakout from wild and loose cup and handle bases, but failed to make much progress and the relative strength lines are lagging. Home builders, Toll Brothers (TOL), Lennar (LEN), and Standard Pacific (SPF), have attempted to build cup and handle bases, but the relative strength lines have lagged and the consolidation are wild and loose. Oil and Gas stocks have been the clear leaders, Sanchez Energy (SN) and Pioneer Natural Resources (PXD).

The divergence between market direction and sell signals has become "normal" stock market behavior over the last year and a half, during rallies for short periods of time. But when the convergence begins, traders and investors had little time to react. Hard earned profits vanished and quickly turned into losses if traders hesitated to protect profits and minimize losses. 

The market is in a perfect position to frustrate longs and shorts at the same time, slowly killing them from over trading, a death by a thousand cuts. Traders should be extremely selective with new positions and hold only well behaving positions. Without hesitation, protect profits in over extended positions, and book minor profits or minimize losses in lagging stocks. Better safe then sorry with all the sell signals.